A medical technology venture firm founded in 2013 and based in the Northeast USA makes equity investments in early stage companies developing products to accelerate the trend of precision medicine. The firm seeks a leading investment position and deep involvement with its portfolio companies. Typical investment ranges from $15-20 M and is calibrated to milestone attainment. With a global view and global operational capabilities, the firm is currently seeking opportunities across the world.
The firm focuses three market segments that support knowledge-generating precision medicine: 1) mobile health, data analytics, and healthcare IT; 2) high specificity in-vivo and in-vitro diagnostics; and 3) guided and personalized minimally invasive therapies. The firm is looking for technologies that will dramatically improve patient health and have the potential for global markets and scale.
The firm is looking for experienced management teams with deep domain expertise. The firm typically request board representation post-investment.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org